Latest Sironax News & Updates

See the latest news and media coverage for Sironax. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Sironax

Biotech developing therapies for degenerative diseases

sironax.com
Headquarters
Waltham, United States
Founded year
2017
Company type
Private company
Number of employees
60–200

Last updated

Latest news about Sironax

In short: Sironax advanced its clinical pipeline, secured FDA Fast Track designation for SIR2501, and raised $200 million to fund its RIPK1 programs.

Company announcements

Sironax

Sironax appoints Clive Wang to Board of Directors

Clive Wang, Managing Director at YF Capital, brings extensive life sciences investment experience. Dr. Shefali Agarwal praises his addition as the company advances clinical programs.

Sironax

Sironax appoints two senior vice presidents

Nasir Khan joins as SVP, Preclinical Development effective 2025-10-20 and Gary Ingenito as SVP, Clinical Development effective 2025-11-01. Both report to CEO Shefali Agarwal in Waltham.

Unlock all announcements with a

Media coverage

Pharmaphorum

Chinese biotech Sironax raises $200m for RIPK1 pipeline

Beijing biotech Sironax has closed a whopping $200 million second-round financing that shows investors still have a desire to back companies working on RIPK1 inhibitors...

Unlock all articles with a

Never miss news about Sironax

Track Sironax and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Sironax competitors & trending companies

Browse news for competitors to Sironax and other trending companies.